3-Tert-butyl-4-methylphenol | 133-72-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-Tert-butyl-4-methylphenol
• CAS: 133-72-2
• 化学式: C₁₁H₁₆O
• 分子量: 164.24
• InChiKey: OBYOFMNDYOOIPV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.5
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-硝基苯重氮氯化物 、 3-Tert-butyl-4-methylphenol 生成 2-(Benzotriazol-2-yl)-5-tert-butyl-4-methylphenol
  参考文献：
  名称：

  MARKOV, V. I.;SMOLENSKIJ, I. N.;GONTAR, S. S., VOPR. XIMII I XIM. TEXNOL., XARKOV, 1983, N 72, 70-79

  摘要：

  DOI：

文献信息

• 4-Hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them
  申请人：——

  公开号：US20030162789A1

  公开（公告）日：2003-08-28

  The present invention relates to 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them. More particularly, it relates to 4-hydroxycinnamamide derivatives showing superior antioxidant activity compared to the known antioxidant compounds, their pharmaceutically acceptable salt, and pharmaceutical compositions containing them. It can be usefully used in treating neurodegerative diseases such as aging, cancer, diabetes, ischemic stroke, Parkin's disease, dementia and Huntinton's disease.

  本发明涉及4-羟基肉桂酰胺衍生物作为抗氧化剂以及含有它们的药物组合物。更具体地，它涉及4-羟基肉桂酰胺衍生物，其显示出比已知抗氧化剂化合物更优越的抗氧化活性，它们的药用可接受盐，以及含有它们的药物组合物。它可以有效用于治疗神经退行性疾病，如衰老、癌症、糖尿病、缺血性中风、帕金森病、痴呆症和亨廷顿病。
• Perhydrolase
  申请人：Amin Neelam S.

  公开号：US20080145353A1

  公开（公告）日：2008-06-19

  The present invention provides methods and compositions comprising at least one perhydrolase enzyme for cleaning and other applications. In some particularly preferred embodiments, the present invention provides methods and compositions for generation of peracids. The present invention finds particular use in applications involving cleaning, bleaching and disinfecting.

  本发明提供了一种包括至少一种过氧化酶酶的方法和组合物，用于清洁和其他应用。在一些特别优选实施例中，本发明提供了用于生成过氧酸的方法和组合物。本发明在涉及清洁、漂白和消毒的应用中具有特殊用途。
• [EN] PRODRUG COMPOSITIONS AND METHODS OF TREATMENT<br/>[FR] COMPOSITIONS DE PROMÉDICAMENT ET PROCÉDÉS DE TRAITEMENT
  申请人：AQUESTIVE THERAPEUTICS INC

  公开号：WO2021087359A1

  公开（公告）日：2021-05-06

  Pharmaceutical compositions include a prodrug of epinephrine are described.

  药物组合物包括表述的肾上腺素前药。
• Novel proton type beta zeolite, preparation method thereof and process for preparing phenol compound using the same
  申请人：UBE INDUSTRIES, LTD.

  公开号：US20040242938A1

  公开（公告）日：2004-12-02

  Disclosed are a proton type &bgr; zeolite in which an acid site showing a desorption peak with a range of ±100° C. with a center of 330° C. exists in a spectrum measured by the ammonia temperature programmed desorption method (NH 3 -TPD), and an amount of a strong acid site showing a desorption peak of 500° C. or higher is controlled to 2.5 &mgr;mol/g or less, a method for preparing the same, and a process for preparing a phenol compound by oxidizing a benzene compound with a peroxide in the presence of the proton type &bgr; zeolite.

  揭示了一种质子型β沸石，其中通过氨温度程序脱附法（NH3-TPD）测量的光谱中存在一个酸位显示出一个±100°C范围内的脱附峰，中心温度为330°C，并且控制强酸位显示出500°C或更高脱附峰的量为2.5μmol/g或更低，以及制备该沸石的方法和在质子型β沸石存在的情况下，在过氧化物存在下氧化苯化合物制备苯酚化合物的方法。
• ANTI-ESTROGENIC COMPOUNDS
  申请人：PFIZER INC.

  公开号：US20160311805A1

  公开（公告）日：2016-10-27

  The present disclosure provides a compound of Formula I: or a pharmaceutically acceptable salt wherein X, R 1 -R 8 , Y 1 -Y 5 , m, n, p, and q are defined herein. The novel 2H-chromene compounds are useful for the modulation of disorders mediated by estrogen, and other disorders, as described herein. The present invention also relates to pharmaceutical compositions containing the compounds and to methods of using the compounds and compositions.

  本公开提供一种具有以下化学式的化合物：或其药用可接受盐，其中X、R1-R8、Y1-Y5、m、n、p和q在此处定义。这些新型2H-香豆素化合物对通过雌激素介导的疾病和其他疾病的调节具有用处，如本文所述。本发明还涉及含有这些化合物的药物组合物以及使用这些化合物和组合物的方法。